Related Experiment Video
Updated: Jan 21, 2026

Reproducible Motor Deficit Following Aortic Occlusion in a Rat Model Of Spinal Cord Ischemia
Published on: July 22, 2017
Effects of mTOR on Neurological Deficits after Transient Global Ischemia
1Department of Emergency Medicine, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
Abstract:
Mammalian target of rapamycin (mTOR) is a serine/threonine protein kinase and activation of its signal pathway plays an important role in regulating protein growth and synthesis as well as cell proliferation and survival. In the present study, we examined the contribution of mTOR and its downstream products to brain injuries and neurological deficiencies after cardiac arrest (CA) induced-transient global ischemia. CA was induced by asphyxia followed by cardiopulmonary resuscitation (CPR) in rats. Our results showed that expression of p-mTOR, mTOR-mediated phosphorylation of 4E-binding protein 4 (4E-BP1) and p70 ribosomal S6 protein kinase 1 (S6K1) pathways were amplified in CA rats compared to their controls. Blocking mTOR using rapamycin attenuated upregulation of pro-inflammatory cytokines (namely IL-1β, IL-6 and TNF-α), and Caspase-3, indicating cell apoptosis and also promoting the levels of vascular endothelial growth factor (VEGF) and its subtype receptor VEGFR-2 in the hippocampus. Moreover, the effects of rapamycin were linked to improvement of neurological deficits and increased brain water content observed in CA rats. In conclusion, activation of mTOR signal is engaged in pathophysiological process during CA-induced transient global ischemia and blocking mTOR pathway plays a beneficial role in regulating injured neuronal tissues and neurological deficits via PIC, apoptotic Caspase-3 and VEGF mechanisms. Targeting one or more of these specific mTOR pathways and its downstream signaling molecules may present new opportunities for neural dysfunction and vulnerability related to transient global ischemia.
Insights
Blocking the mammalian target of rapamycin (mTOR) pathway reduces brain damage and neurological deficits after cardiac arrest. This mTOR inhibition lessens inflammation, apoptosis, and improves vascular endothelial growth factor (VEGF) levels in the hippocampus.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- The mammalian target of rapamycin (mTOR) pathway regulates crucial cellular processes like growth, proliferation, and survival.
- Activation of mTOR signaling is implicated in various pathological conditions, including brain injury.
Purpose of the Study:
- To investigate the role of the mTOR pathway in brain injuries and neurological deficits following transient global ischemia induced by cardiac arrest (CA).
- To evaluate the therapeutic potential of blocking mTOR signaling using rapamycin in a rat model of CA-induced ischemia.
Main Methods:
- Transient global ischemia was induced in rats via asphyxia followed by cardiopulmonary resuscitation (CPR).
- Expression levels of p-mTOR, phosphorylated 4E-binding protein 4 (4E-BP1), and p70 ribosomal S6 protein kinase 1 (S6K1) were assessed.
- The effects of rapamycin treatment on pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), Caspase-3, vascular endothelial growth factor (VEGF), and its receptor VEGFR-2 were analyzed.
- Neurological deficits and brain water content were evaluated.
Main Results:
- mTOR pathway activation (increased p-mTOR, p-4E-BP1, p-S6K1) was observed in rats subjected to CA.
- Rapamycin treatment attenuated the upregulation of pro-inflammatory cytokines and Caspase-3, indicating reduced inflammation and apoptosis.
- Blocking mTOR with rapamycin promoted VEGF and VEGFR-2 levels in the hippocampus.
- Rapamycin administration led to improved neurological function and reduced brain water content in CA rats.
Conclusions:
- Activation of the mTOR signaling pathway contributes to the pathophysiology of CA-induced transient global ischemia.
- Inhibition of the mTOR pathway with rapamycin demonstrates neuroprotective effects.
- Targeting mTOR signaling pathways offers a promising therapeutic strategy for mitigating neural dysfunction and vulnerability associated with transient global ischemia.
Related Concept Videos
Introduction to Global Positioning System
Global Climate Change
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Series R—L Circuit Transients
Using Kirchhoff's Voltage Law (KVL) to analyze this circuit helps determine the total asymmetrical fault current, which consists...

